Britta Fuenfstueck
About
Britta Fuenfstueck is from Germany. Britta is currently Board Member and CEO at HARTMANN GROUP, located in CEO since January 1, 2019 // Heidenheim, Germany. In Britta's previous role as a Executive Committee Member at Clariant, Britta worked in Switzerland until Oct 2018. Prior to joining Clariant, Britta was a Manager at Siemens and held the position of Manager at Germany. Prior to that, Britta was a Manager at Siemens, based in Greater Chicago Area, USA from Jan 2009 to Jan 2013. Britta started working as Manager at Siemens in Germany and USA in Jan 2000. From Jan 1998 to Jan 2000, Britta was Consultant at The Boston Consulting Group, based in Austria.
You can find Britta Fuenfstueck's email on finalScout.com. FinalScout is a popular professional database with more than 500 million business professionals and over 200 million company profiles.
Britta Fuenfstueck's current jobs
CEO and Chair of the Management Board at HARTMANN GROUP, a leading global provider of medical and hygiene products.
Britta Fuenfstueck's past jobs
Member of the Executive Committee of Clariant with responsibilities for Business Area Plastics & Coatings as well as Group Information Technology, Group Procurement, Digital4Clariant, Commercial Excellence, Operational Excellence, Supply Chain Excellence, and the regions Latin America and North America. Building New Digital Business Models and Building strong marketing organizations are amongst key initiatives, which are key drivers for profitable growth.
Siemens Healthcare: Division CEO Clinical Products and Member of Executive Committee Responsible for business units and the initiation of several programs in commercialization / business partner management, production platform design and portfolio management
Siemens Healthcare: CEO Nuclear Medicine Siemens (PET/CT, SPECT, SPECT/CT, PETNET, MI-BiomarkerResearch, preclinical, cyclotrons)
Siemens Healthcare: Various roles in Portfolio Planning, Marketing, Business Development, and Product Management; last role: Head of Strategy and M&A